At Controlling Shareholder's Request, Bausch + Lomb Overhauls Board and Reaffirms Guidance
BLCO sits 24% above its 52-week low of $13.53.
Summary
At the request of controlling shareholder Bausch Health, Bausch + Lomb replaced four directors with four new members, including Bausch Health's CEO. The company also reaffirmed its 2026 guidance and highlighted improved Q2 cash flow.
Key Events · Executive and Board Changes · BLCO
-
Board Overhaul at Controlling Shareholder's Request
Effective August 5, 2026, four directors resigned and four new directors were appointed at the request of Bausch Health Companies Inc., which owns approximately 87% of Bausch + Lomb. Among the new appointees is Thomas J. Appio, CEO of Bausch Health.
-
Consulting Agreement with Departing Director
Departing director Thomas W. Ross, Sr. entered a one-year consulting agreement with the company for a total fee of $400,000, payable in quarterly installments of $100,000.
-
2026 Guidance Reaffirmed
Full-year 2026 guidance was reaffirmed, including revenue of $5.440 billion to $5.540 billion and Adjusted EBITDA excluding Acquired IPR&D of $1.025 billion to $1.075 billion.
-
Q2 2026 Financial Highlights Disclosed
Second-quarter revenue reached $1.394 billion (+9% YoY), with net cash from operations of $153 million and adjusted cash flow from operations of $161 million—both significantly improved from Q1 2026.
Analysis · BLCO · Industrial Applications And Services
At the request of Bausch Health, its 87% controlling shareholder, Bausch + Lomb replaced four directors with four new appointees, including Bausch Health's CEO—a move that signals tighter alignment with the parent. The company also reaffirmed its recently raised 2026 guidance and disclosed strong Q2 cash flow, which may cushion any governance concerns. While the board shake-up is a material governance event, the reaffirmed outlook and the absence of disagreement among departing directors limit the negative impact.
At the time of this filing, BLCO was trading at $16.76 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6B. The 52-week trading range was $13.53 to $18.92. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.